Company intelligence / Profile preview

Molteni Farmaceutici

Scandicci/Florence, Tuscany, Italymoltenifarma.it ↗

Ownership: Private
Employees: ~374
Development stage: Commercial

Overview

Molteni Farmaceutici has a long-standing commercial presence in opioid-based therapies and anesthetics, with proprietary and licensed products distributed in over thirty-five countries. The company also develops medical devices and has a history of innovation through internal R&D and academic collaborations.

Therapeutic areas: EndocrinologyPsychiatryNeurology
Modalities: Small molecules (opioids, anesthetics)Medical devices for wound carePhotosensitizing molecules (via subsidiary)
Industry: Biotech

Drug pipeline

2 assets

RLP068

1 more asset in the full pipeline.

Request access →

Partnerships

SteinCares—exclusive marketing/distribution partnership for Oramorph® in Latin America

Beyond the preview

Go deeper on Molteni Farmaceutici.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molteni Farmaceutici.

Explore the full profile